Why Dental Implants Are Made of Titanium (and When Zirconia Is Used Instead)

Titanium's role in implant dentistry traces back to a 1952 laboratory accident in which Swedish orthopedic surgeon Per-Ingvar Branemark was studying blood flow in rabbit bone using a titanium optical chamber. When the experiment ended, the titanium device could not be removed: the bone had grown directly onto its surface. Branemark recognized that he had discovered something significant, and spent the following decade investigating whether the same fusion could be achieved predictably in humans. By 1965, the first titanium dental implant was placed in a human patient, and that patient retained the implant until his death in 2006.

Titanium's properties make it unusually well-suited for permanent implantation in bone. It is lightweight relative to its strength, highly resistant to corrosion in the biological environment of the body, and it does not trigger an immune response or allergic reaction in the vast majority of patients. Most metals oxidize and degrade over time in the presence of body fluids. Titanium forms a stable oxide layer on its surface almost instantly upon exposure to air or fluid, and this layer is chemically inert. The body does not recognize it as a foreign threat.

The alloy used in most implants today is titanium grade 4 or the titanium-aluminum-vanadium alloy Ti-6Al-4V, rather than pure titanium. The alloyed version is significantly stronger, allowing thinner implant profiles in narrow-ridge situations without sacrificing structural integrity. For patients with documented metal sensitivities, grade 4 commercially pure titanium is preferred, as it contains no aluminum or vanadium.

Osseointegration is not a single event but a biological process that unfolds over months. When a titanium implant is placed in prepared bone, blood immediately contacts the surface and a protein layer forms within seconds. This protein layer becomes the scaffold for the biological cascade that follows. Platelets aggregate, a fibrin clot forms, and osteogenic cells (bone-forming cells) begin migrating toward the surface from the surrounding bone.

Within the first few weeks, woven bone, the initial rough-textured bone produced during healing, begins forming at the implant surface. Over the following months, this woven bone is replaced by lamellar bone, the mature, organized bone that provides load-bearing strength. The transition from initial stability (mechanical, from press-fit during placement) to secondary stability (biological, from osseointegration) typically takes three to six months. During this window, excessive loading disrupts the forming bone-implant interface and can cause fibrous tissue to form instead of bone, which constitutes integration failure.

Implant surface texture is engineered to accelerate this process. Rough surfaces achieved through acid etching, sandblasting, or plasma spraying create more surface area for protein adsorption and cell attachment than smooth-machined surfaces. Clinical studies comparing smooth first-generation implants to modern rough-surface implants show meaningfully shorter integration times and higher success rates with roughened surfaces. Some manufacturers apply a calcium phosphate coating to further promote early bone cell activity.

Different implant manufacturers have developed proprietary surface treatments, each with supporting clinical data. Straumann's SLA (sandblasted, large grit, acid-etched) surface is one of the most extensively studied, with over twenty years of clinical data. Nobel Biocare's TiUnite surface uses an oxidized titanium surface with a slightly thicker oxide layer that changes the microstructure at the bone-implant interface. Dentsply Sirona's OsseoSpeed uses a fluoride-modified surface intended to accelerate early bone mineralization.

Hydroxyapatite-coated implants were popular in the 1980s and 1990s. The hydroxyapatite coating, which chemically resembles the mineral phase of bone, promoted rapid initial bone attachment. However, long-term data showed that the coating could fracture, delaminate, or dissolve over years, leaving behind a roughened surface that harbored bacteria. Most mainstream manufacturers have moved away from thick hydroxyapatite coatings, though some use thin crystalline coatings with better durability.

All of these surface variations outperform first-generation smooth titanium implants. In the clinical context that matters most, the differences between modern rough-surface systems from major manufacturers are smaller than the differences introduced by patient health factors, surgical technique, and long-term maintenance. Surface technology matters, but it is not the primary determinant of outcomes in routine cases.

Zirconia (zirconium dioxide, ZrO2) implants have been marketed as a metal-free alternative to titanium, appealing to patients with aesthetic concerns about dark metal near the gum line or with documented metal sensitivities. Zirconia is white rather than gray, so in patients with thin gum tissue, there is no risk of a gray shadow showing through the gum around the implant neck. For anterior (front) implants in patients with thin tissue biotypes, this is a legitimate aesthetic advantage.

The clinical record for zirconia implants is substantially shorter than for titanium. Titanium implants have fifty-plus years of data with well-understood failure modes. Zirconia implants have roughly fifteen to twenty years of published data, and the longer-term behavior is less characterized. Early zirconia designs were one-piece (the implant body and abutment are a single unit), which eliminated the mechanical connection between the two components but made restorative flexibility significantly more limited. Two-piece zirconia systems have improved this, but the connection interfaces are not as extensively validated as titanium connections.

Zirconia is also more brittle than titanium. In laboratory testing, zirconia implants tolerate fatigue loading less well than titanium equivalents of the same diameter, which has led to conservative diameter recommendations and caution about their use in posterior high-load areas. Current consensus is that zirconia implants are a reasonable choice for appropriately selected anterior cases in the hands of experienced surgeons, but titanium remains the default for posterior teeth, full-arch cases, and any situation where long-term biomechanical demands are high.

True titanium allergy is rare, estimated in the range of less than one percent of patients, and differs from common nickel or cobalt-chromium sensitivities that affect a much larger segment of the population. Titanium does not contain nickel. Patients with jewelry sensitivities are typically reacting to nickel, not titanium, and this sensitivity does not predict a reaction to titanium implants.

That said, case reports of peri-implant reactions attributed to titanium particle release or hypersensitivity exist in the literature, though they are uncommon. Patients with multiple metal sensitivities, documented reactions to surgical implants, or significant inflammatory conditions may reasonably ask whether zirconia is a better option for their situation. A lymphocyte transformation test (LTT) or MELISA test can assess reactivity to titanium and other metals before placement if there is genuine clinical concern.

For the vast majority of patients, titanium is a biocompatible, well-tolerated material with a safety record spanning decades. The concerns about titanium that circulate in wellness communities are generally not supported by the published implant literature, and the decision to choose zirconia based on vague metal fears rather than specific clinical factors is not currently supported by evidence.

For most patients replacing a missing molar or premolar, a titanium implant from a major manufacturer with a modern rough surface is the appropriate choice. The fifty-year track record, the full range of diameter and length options, and the extensively validated restorative components make it the standard of care for good reason. The specific brand within this category is less important than the surgeon's familiarity with the system and the quality of the full treatment plan.

If you have thin gum tissue in a visible anterior area, strong aesthetic preferences about metal near the gum line, or a documented metal sensitivity, a conversation about zirconia implants is worth having. Your dentist can assess your tissue thickness, review your medical history, and help you weigh whether zirconia is the right tool for your specific anatomy and goals.

The implant material is one variable in a multi-variable decision. The quality of the surgical plan, the adequacy of the bone, and the long-term maintenance commitment you bring to the restoration will each have a larger effect on thirty-year outcomes than the choice between comparable titanium systems.